These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia. Akashi K, Mizuno S, Harada M, Kimura N, Kinjyo M, Shibuya T, Shimoda K, Takeshita M, Okamura S, Matsumoto I. Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698 [Abstract] [Full Text] [Related]
6. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement. Yoshida T, Kimura N, Sawada H, Suematsu E, Nagano M, Akiyoshi T, Motomura S, Kikuchi M, Nishimura J, Tamura K. Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360 [Abstract] [Full Text] [Related]
7. A child case of CD34+, CD33-, HLA-DR-, CD7+, CD56+ stem cell leukemia with thymic involvement. Nagata T, Higashigawa M, Nagai M, Zhang XL, Azuma E, Komada Y, Sakurai M. Leuk Res; 1996 Jul; 20(11-12):983-5. PubMed ID: 9009257 [Abstract] [Full Text] [Related]
9. [Cytokine in phenotypic analysis of leukemia/lymphoma: suppression of gene expression of myeloperoxidase by IFN-gamma and subset of AML M1 defined by CD45RO+/RA-, CD7(-), CD34(-) and non-inducible HLA-DR antigen]. Tatsumi E, Yoneda N, Kawano S, Yamaguchi N. Rinsho Byori; 1993 Apr; 41(4):377-83. PubMed ID: 7688832 [Abstract] [Full Text] [Related]
10. [CD7 positive undifferenciated leukemia/lymphoma associated with leukemic pericarditis]. Ochi K, Amano M, Soda Y, Togawa A, Takaku F. Rinsho Ketsueki; 1994 Jul; 35(7):665-9. PubMed ID: 7520512 [Abstract] [Full Text] [Related]
11. Clinical significance of CD7-positive stem cell leukemia. A distinct subtype of mixed lineage leukemia. Yumura-Yagi K, Hara J, Kurahashi H, Okamura J, Koizumi S, Toyoda Y, Murayama N, Inoue M, Ishihara S, Tawa A. Cancer; 1991 Nov 15; 68(10):2273-80. PubMed ID: 1717122 [Abstract] [Full Text] [Related]
12. Biphenotypic leukemic lymphocyte precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues. Uckun FM, Muraguchi A, Ledbetter JA, Kishimoto T, O'Brien RT, Roloff JS, Gajl-Peczalska K, Provisor A, Koller B. Blood; 1989 Mar 15; 73(4):1000-15. PubMed ID: 2784064 [Abstract] [Full Text] [Related]
13. [CD7, HLA-DR, CD38 positive acute undifferentiated leukemia with subcutaneous tumor and thymoma]. Doi T, Sakamaki S, Koike K, Matsunaga T, Kobayashi D, Muramatsu H, Sato T, Watanabe N, Kougo Y, Niitsu Y. Rinsho Ketsueki; 1996 Aug 15; 37(8):676-81. PubMed ID: 8827877 [Abstract] [Full Text] [Related]
18. [Immunologic characteristics and prognosis of acute myeloid leukemia M1]. Zhao F, Chen Y. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug 15; 15(4):687-91. PubMed ID: 17708783 [Abstract] [Full Text] [Related]
19. Expression of MDR1 gene in acute leukemia cells: association with CD7+ acute myeloblastic leukemia/acute lymphoblastic leukemia. Miwa H, Kita K, Nishii K, Morita N, Takakura N, Ohishi K, Mahmud N, Kageyama S, Fukumoto M, Shirakawa S. Blood; 1993 Dec 01; 82(11):3445-51. PubMed ID: 7694687 [Abstract] [Full Text] [Related]
20. Relation of some cytochemical activities to the expression of CD34 marker in acute leukemia. Klobusická M, Babusíková O, Hrivnáková A. Neoplasma; 1993 Dec 01; 40(5):309-14. PubMed ID: 7505888 [Abstract] [Full Text] [Related] Page: [Next] [New Search]